Item 5.07 Submission of Matters to a Vote of Security Holders.

The 2023 Annual Meeting of Stockholders (the "Annual Meeting") of Inhibrx, Inc. (the "Company") was held on May 25, 2023 at 10:00 a.m. Pacific Time online in a virtual format. Of the Company's 43,594,892 shares of common stock issued and outstanding and eligible to vote as of the record date of March 27, 2023, a quorum of 40,881,671 shares, or approximately 94% of the eligible shares, was present virtually or represented by proxy. Each of the matters set forth below is described in detail in the Company's definitive proxy statement filed with the Securities and Exchange Commission on April 13, 2023. The following actions were taken at the Annual Meeting:

Proposal 1

Election of the following nominee as Class III Director of the Company, to serve until the 2026 Annual Meeting and until his successor is duly elected and qualified.


                   Votes For    Votes Withheld     Broker Non-Votes
Mark P. Lappe      36,130,563      1,777,302          2,973,806



Proposal 2

Ratification of the selection of BDO USA, LLP as the Company's independent registered public accounting firm for the year ending December 31, 2023.



 Votes For     Votes Against    Votes Abstained    Broker Non-Votes
 40,787,752        2,408            91,511                -



Proposal 3

Advisory vote to approve the compensation of the Company's named executive officers.

Votes For Votes Against Votes Abstained Broker Non-Votes


 35,944,811      1,960,304           2,750            2,973,806

© Edgar Online, source Glimpses